KAI-1455

KAI-1455 is a selective epsilon protein kinase C (εPKC) activator designed to reduce ischemic organ injury during procedures where blood supply may be compromised, such as coronary artery bypass grafting (CABG), congenital cardiac defect repair, and hip replacement and may protect against renal injury associated with contrast media.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	10-101-145
Synonyms/Alias	KAI 1455;KAI1455
M.F/Formula	C109H180N44O30S2
M.W/Mr.	2652
Sequence	H-Cys(1)-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH. H-Cys(1)-His-Asp-Ala-Pro-Ile-Gly-Tyr-Asp-OH
Labeling Target	Epsilon protein kinase C (εPKC)
Activity	Activator
Functions	Signal transducer activity
Target	εPKC

CAT#	Product Name	Inquiry
10-101-212	Thymosin β4 (1-4)	Inquiry
10-101-241	H-D-Leu-Thr-Arg-PNA	Inquiry
10-101-130	Zonisamide	Inquiry
10-101-325	Semaglutide	Inquiry
10-101-23	Lysipressin	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Storage	-20℃
Organism	Human